{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
BioArk drives innovation and business growth from early stages to commercialization. With two technology parks in Valais and over 10,000 jobs, our ecosystem offers cutting-edge facilities, expert coaching, funding support, and a strong industrial and scientific network.
Ceidos is a Swiss biotech company developing the C-Netics, an innovative device for automated cell culture monitoring. Their mission is to optimize bioproduction processes for modern treatments through automation and innovative technologies.
Novochizol SA researches and develops applications of Novochizol, a unique chitosan nanoparticle technology that yields different carriers of small molecules, peptides, nucleic acids and proteins for sustained, localized delivery to any living tissue, with intracellular targeting potential.
Precise Health develops AI-powered platforms for bacteriophage discovery, host-matching, and engineering. We serve hospitals, biotech, and pharma in the $50B+ anti-infectives and diagnostics markets, addressing the urgent global threat of antimicrobial resistance
At Stämm we develop accessible, plug & play biomanufacture solutions; allowing an automatized, continuous and more efficient production of biologics and cell therapies while managing media conditions. We have reinvented biomanufacturing by providing an alternative to the known biomass production.
Curio Biotech is a CRO providing personalized Contract Research Services to Clients in Pharma/Nutrition and Cosmetic sectors. Services: In vitro - Biology (Drug Discovery), Efficacy, Safety, Pharmocology, Mechanism of Action, Bioassays.
GaDia is the first company helping healthcare professionals to diagnose healthcare-acquired fungal infections in 15 minutes.
IBEX Therapeutics SA developd an innovative mouthwash and a portfolio of products based on medicinal plant extracts, to prevent and treat chemoradiotherapy-induced oral mucositis in patients with cancer.
Phi Pharma SA is developing a new class of anti-cancer drugs: Peptide Drug Conjugates (PDCs) effective in multiple human cancers using an innovative mechanism of cell entry: novel CSPG4 targeting bio-pharmaceuticals.
On mandates of chemical, pharmaceutical, agrochemical and biotechnology industries, we study the electrochemical alternative for redox transformation steps and waste water treatment of refractory organic compounds. We perform process optimization in the laboratory and conduct the scale-up to the industrial le
Sysmatec offers laboratory automation systems and software, scientific software and a wide range of laboratory equipment (material for biotechnology, chemistry…). The most devices presented here can be connected to a computer with our software.
YONI Solutions is a women's health company focused on Vaginal Microbiome Analysis and our own Personalised Probiotic recommendation to improve women's health and quality of life.